Work

Clinical potential of mass spectrometry-based proteogenomics

Year: 2018

Type: review

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/s41571-018-0135-7

Authors: Bing Zhang, Jeffrey R. Whiteaker, Andrew N. Hoofnagle, Geoffrey S. Baird, Karin D. Rodland, Amanda G. Paulovich

Institutions: Baylor College of Medicine, Fred Hutch Cancer Center, University of Washington, Pacific Northwest National Laboratory, Oregon Health & Science University

Language: English

Topic: Advanced Proteomics Techniques and Applications

Subfield: Spectroscopy

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1731932032, Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit, G2358021521, G649405981, Diabetes Research Center

OpenAlex ID: W2902452126

FWCI: 1.719

Cites: 169

Cited by: 210

Related to: 10